CRISPR gene-editing has been hailed as a breakthrough that could eradicate diseases
Several US trials of the technology in humans are underway
The University of Pennsylvania told NPR they have edited the genes of their first two adult human patients to treat sarcoma and myeloma
Two human patients have had their genes edited in one of several clinical trials of CRISPR now underway in the US.
The University of Pennsylvania is using the ground-breaking - and at times controversial - technology to treat patients with myeloma.
A spokesperson for the university confirmed that two patients there have been treated in an email to NPR.